The role of squamous cell carcinoma antigen (SCC Ag) in outcome prediction after concurrent chemoradiotherapy and treatment decisions for patients with cervical …

J Fu, W Wang, Y Wang, C Liu, P Wang - Radiation Oncology, 2019 - Springer
At present, the standard treatment approach for locally advanced cervical cancer is
concurrent chemoradiotherapy (CCRT). An elevated pretreatment squamous cell carcinoma …

[HTML][HTML] The association between serum squamous cell carcinoma antigen and recurrence and survival of patients with cervical squamous cell carcinoma: a …

C Charakorn, K Thadanipon, S Chaijindaratana… - Gynecologic …, 2018 - Elsevier
Objective The aim of this systematic review and meta-analysis was to pool association
effects of serum squamous cell carcinoma antigen (SCC-Ag) on recurrence and mortality in …

Skeletal muscle loss is an imaging biomarker of outcome after definitive chemoradiotherapy for locally advanced cervical cancer

J Lee, CL Chang, JB Lin, MH Wu, FJ Sun, YT Jan… - Clinical Cancer …, 2018 - AACR
Purpose: This study investigates the association between body composition change during
concurrent chemoradiotherapy (CCRT) and outcome in patients with locally advanced …

Pelvic lymph node F‐18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer

EA Kidd, BA Siegel, F Dehdashti… - … International Journal of …, 2010 - Wiley Online Library
BACKGROUND: The objective of the current study was to evaluate the prognostic
significance of the maximum standardized uptake value (SUVmax) of F‐18 …

Long-term outcome and prognostic factors for adenocarcinoma/adenosquamous carcinoma of cervix after definitive radiotherapy

YT Huang, CC Wang, CS Tsai, CH Lai… - International Journal of …, 2011 - Elsevier
PURPOSE: To study the outcomes of patients with adenocarcinoma/adenosquamous
carcinoma (AC/ASC) of the cervix primarily treated with radiotherapy (RT), identify the …

Impact of tumor size on survival in cancer of the cervix and validation of stage IIA1 and IIA2 subdivisions

AE Wagner, L Pappas, AJ Ghia, DK Gaffney - Gynecologic oncology, 2013 - Elsevier
OBJECTIVE: A change has recently been made to the Federation of Gynecology and
Obstetrics (FIGO) staging system for cervical cancer to account for size within stage IIA …

Prognostic nomogram for overall survival in stage IIB-IVA cervical cancer patients treated with concurrent chemoradiotherapy

JY Tseng, MS Yen, NF Twu, CR Lai, HC Horng… - American journal of …, 2010 - Elsevier
OBJECTIVE: On the basis of outcome data from concurrent chemoradiotherapy (CCRT) for
locally advanced cervical squamous cell carcinoma, the authors developed a nomogram for …

Prophylactic lower para-aortic irradiation using intensity-modulated radiotherapy mitigates the risk of para-aortic recurrence in locally advanced cervical cancer: A 10 …

J Lee, JB Lin, CL Chang, YT Jan, FJ Sun, MH Wu… - Gynecologic …, 2017 - Elsevier
Objective To evaluate the effects of prophylactic sub-renal vein radiotherapy (SRVRT) using
intensity-modulated radiotherapy (IMRT) for cervical cancer. Methods A total of 206 patients …

A prospective randomized trial to study the impact of pretreatment FDG-PET for cervical cancer patients with MRI-detected positive pelvic but negative para-aortic …

CS Tsai, CH Lai, TC Chang, TC Yen, KK Ng… - International Journal of …, 2010 - Elsevier
PURPOSE: This prospective randomized study was undertaken to determine the possible
impact of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) on extrapelvic …

Functional imaging to predict tumor response in locally advanced cervical cancer

TD Barwick, A Taylor, A Rockall - Current oncology reports, 2013 - Springer
Worldwide, cervical cancer is the third commonest cancer. Prognostic factors for cervical
cancer include tumor size, histological subtype, histological grade, International Federation …